Reuters logo
BRIEF-Forward Pharma Files Further Written Submissions In European Opposition Proceeding For EP2801355 Patent
November 29, 2017 / 10:02 PM / 17 days ago

BRIEF-Forward Pharma Files Further Written Submissions In European Opposition Proceeding For EP2801355 Patent

Nov 29 (Reuters) - Forward Pharma A/S:

* FORWARD PHARMA FILES FURTHER WRITTEN SUBMISSIONS IN THE EUROPEAN OPPOSITION PROCEEDING FOR THE EP2801355 PATENT IN PREPARATION FOR THE ORAL HEARING IN JANUARY 2018

* FORWARD PHARMA A/S - FILING OF FURTHER WRITTEN SUBMISSIONS IN EUROPEAN OPPOSITION PROCEEDING FOR EP2801355 PATENT WITH EPO

* FORWARD PHARMA A/S - FILING WILL BECOME PUBLICLY AVAILABLE VIA EUROPEAN PATENT REGISTER

* FORWARD PHARMA A/S - AN ORAL HEARING IS CURRENTLY SCHEDULED FOR JANUARY 29-30, 2018

* FORWARD PHARMA A/S - POSSIBILITY TO APPEAL DECISION OF OPPOSITION DIVISION TO TECHNICAL BOARD OF APPEAL Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below